ReviewAdvances in experimental medicine and biology2026
Proteomic Technology.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The proteome is defined as the total protein complement of a genome-whether that genome is associated with an individual cell, tissue, or organism (Wasinger et al., Electrophoresis 16:1090-1094, 1995). Proteomics refers to the application of technologies to characterize the proteome. The term "proteome" was coined by researchers at the University of Sydney, Australia, in a paper published in 1995 (Wasinger et al., Electrophoresis 16:1090-1094, 1995). But did proteomics really begin in 1995 or were researchers doing proteomic research long before? As a PhD student, I would tell people that my field of expertise was protein science, as I was involved in determining the three-dimensional structures of proteins using nuclear magnetic resonance (NMR) spectroscopy. As my career evolved to using mass spectrometry (MS) to analyze complex mixtures of proteins, my field of expertise was proteomics. While still studying proteins, what had changed was the number of proteins I was analyzing per experiment. In a nutshell, proteomics is simply the large-scale study of proteins. While protein scientists have been studying proteins for almost 200 years (Mulder, Bulletin des Sciences Physiques et Naturelles en Néerlande 104, 1838), proteomics has increased the throughput and the ability to characterize proteins in the context of other proteins within their environment. While well-known for its high-throughput ability to identify and quantitate proteins, proteomics encompasses several different facets of protein characterization including such things as structure, function, protein-protein interactions, posttranslational modifications, and protein quantitation. Data acquired under any of these broad categories can be applied to greater understand something part of the cell system.
Indexed as
Identifiers
42129069What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.